An unusual cause of elevated liver function tests in an elderly female

Journal of Clinical Virology

Volumn 51, Issue 2, 2011, Pages 93-95

  Frickmann, Hagen ^a   Gabriel, Martin ^a   Polywka, Susanne ^b   Bonow, Insa ^a   Günther, Stephan ^a   Schmidt Chanasit, Jonas ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Acute hepatitis; Asymptomatic; Genotype 3; Hepatitis E virus; Lifestock associated; Serology

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ALLOPURINOL; CIPROFLOXACIN; CLOPIDOGREL; DIGITOXIN; ENALAPRIL; FORMOTEROL; FUROSEMIDE; GATIFLOXACIN; HYDROCHLOROTHIAZIDE; INSULIN; LEVOTHYROXINE; METOPROLOL; MOLSIDOMINE; OXAZEPAM; PANTOPRAZOLE; QUINOLONE DERIVATIVE; SIMVASTATIN; SPIRONOLACTONE;

ADULT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; LIVER FUNCTION; LIVER FUNCTION TEST; NOTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED, 80 AND OVER; ASYMPTOMATIC DISEASES; CLUSTER ANALYSIS; ENZYMES; FEMALE; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; MOLECULAR SEQUENCE DATA; RADIOGRAPHY, ABDOMINAL; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79956297332     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.02.012     Document Type: Note

References (14)

1. Coleman C.I., Spencer J.V., Chung J.O., Reddy P. Possible gatifloxacin-induced fulminant hepatic failure. Ann Pharmacother 2002, 36:1162-1167.
2. Pischke S., Potthoff A., Hauröder B., Schlué J., Manns M.P., Cornberg M., et al. Hepatitis E virus infection: a paradigm shift?. Dtsch Med Wochenschr 2010, 135:1129-1133.
3. Bächlein C., Grummer B. Hepatitis E-a new zoonotic disease in Germany?. Berl Munch Tierarztl Wochenschr 2010, 123:198-204.
4. Fields virology 1996, 2838. Lippincott-Raven, New York. 3rd edition. N.B. Fields, D.M. Knipe, P.M. Howley (Eds.).
5. Tappe D., Müller A., Ziegler U., Weissbrich B., Schubert J., Günther S., et al. Positive Hepatitis E and Epstein Barr virus serology in a patient with jaundice after travel. J Clin Virol 2010, 48:78-81.
6. Johne R., Plenge-Bönig A., Hess M., Ulrich R.G., Reetz J., Schielke A. Detection of a novel hepatitis E-like virus in faeces of wild rats using a nested broad spectrum RT-PCR. J Gen Virol 2010, 91:750-758.
7. Lu L., Li C., Hagedorn C.H. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 2006, 16:5-36.
8. Aggarwal R., Naik S. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol 2009, 24:1484-1493.
9. Adlhoch C., Wolf A., Meisel H., Kaiser M., Ellerbrock H., Pauli G. High HEV prevalence in four different wild boar populations in East and West Germany. Vet Microbiol 2009, 139:270-278.
10. Schielke A., Sachs K., Lierz M., Appel B., Jansen A., Johne R. Detection of hepatitis E virus in wild boars of rural and urban regions in Germany and whole genome characterization of an endemic strain. Virol J 2009, 6:58.
11. Myint K.S., Gibbons R.V. Hepatitis E: a neglected threat. Trans R Soc Trop Med Hyg 2008, 102:211-212.
12. Kamar N., Rostaing L., Abravanel F., Garrouste C., Lhomme S., Esposito L., et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology 2010, 139:1612-1618.
13. Zhu F.C., Zhang J., Zhang X.F., Zhou C., Wang Z.Z., Huang S.J., et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010, 376:895-902.
14. Mumtaz K., Azam Z., Hamid S., Abid S., Memon S., Ali Shah H., et al. Role of N-acetylcysteine in adults with non-acetaminophen-induced acute liver failure in a center without the facility of liver transplantation. Hepatol Int 2009, [Epub ahead of print].